Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Defining the molecular mechanisms of somatic cell reprogramming

  • Post author:
  • Post published:January 12, 2026
  • Post category:

The development of methods to “reprogram” adult cells such as skin cells by simultaneously expressing four specific factors — Oct3/4, Sox2, c-Myc and Klf4 — in order to create cells…

Continue ReadingDefining the molecular mechanisms of somatic cell reprogramming

Molecular Mechanisms of Reprogramming towards Pluripotency

  • Post author:
  • Post published:January 12, 2026
  • Post category:

Stem cell biology and its applications to cell-based therapies, since its inception 30 years ago, has been hindered by the immunological considerations of rejection of non-autologous cells in patients, as…

Continue ReadingMolecular Mechanisms of Reprogramming towards Pluripotency

Safety “Clinical Trial” of the Cardiac Liability of COVID19 Polytherapy

  • Post author:
  • Post published:September 12, 2024
  • Post category:

Continue ReadingSafety “Clinical Trial” of the Cardiac Liability of COVID19 Polytherapy

Autologous therapy for Parkinson’s disease: single cell RNAseq for in depth characterization of transplanted cells

  • Post author:
  • Post published:September 12, 2024
  • Post category:

Continue ReadingAutologous therapy for Parkinson’s disease: single cell RNAseq for in depth characterization of transplanted cells
  • Go to the previous page
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us